Regulatory T cells for immunotherapy of autoimmune diseases: From the bench to the bedside

Expert Opinion on Therapeutic Patents

Volumn 15, Issue 11, 2005, Pages 1595-1616

  Rutella, Sergio ^a   Danese, Silvio ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Granulocyte colony stimulating factor; IL 10; Regulatory T cell (Treg); Transforming growth factor

Indexed keywords

BASILIXIMAB; CD4 ANTIGEN; CHIMERIC ANTIBODY; FC RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANZYME B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; KM 2760; OKT 3; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; GRAFT VERSUS HOST REACTION; HASHIMOTO DISEASE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 27944507804     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.15.11.1595     Document Type: Review

References (169)

1. RONCAROLO MG, LEVINGS MK, TRAVERSARI C: Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. (2001) 193:F5-F9.
2. VON HERRATH MG, HARRISON LC: Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. (2003) 3:223-232.
3. JONULEIT H, SCHMITT E: The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. (2003) 171:6323-6327.
4. STEINMAN RM, HAWIGER D, NUSSENZWEIG MC: Tolerogenic dendritic cells. Ann. Rev. Immunol. (2003) 21:685-1711.
5. MORELLI AE, THOMSON AW: Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. (2003) 196:125-146.
6. H3 regulatory cells. Immunol. Rev. (2001) 182:207-214.
7. BLUESTONE JA: Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. (2005) 5:343-349.
8. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737-742.
9. BACCHETTA R, BIGLER M, TOURAINE JL et al.: High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J. Exp. Med. (1994) 179:493-502.
10. RONCAROLO MG, BACCHETTA R, BORDIGNON C, NARULA S, LEVINGS MK: Type 1 T regulatory cells. Immunol. Rev. (2001) 182:68-79.
11. H2 gene transcripts. J. Immunol. (2002) 168:1069-1079.
12. COBBOLD SP, NOLAN KF, GRACA L et al.: Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol. Rev. (2003) 196:109-124.
13. LEVINGS MK, SANGREGORIO R, GALBIATI F, SQUADRONE S, DE WAAL MALEFYT R, RONCAROLO MG: IFN-α and IL-10 induce the differentiation of human Type 1 T regulatory cells. J. Immunol. (2001) 166:5530-5539.
14. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature (2003) 421:388-392.
15. - T cells to acquire regulatory cell function. Blood (2003) 101:5076-5083.
16. + regulatory T cells. J. Immunol. (2004) 172:5986-5993.
17. RUTELLA S, LEMOLI RM: Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol. Lett. (2004) 94:11-26.
18. MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. (2001) 19:683-765.
19. + T cells responding to antigen presentation by melanoma cells. Melanoma Res. (1999) 9:173-180.
20. H2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. (2000) 43:617-627.
21. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. (2001) 193:1285-1294.
22. + T cells with regulatory properties from human blood. J. Exp. Med. (2001) 193:1303-1310.
23. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from Type 1 T regulatory cells. J. Exp. Med. (2002) 196:1335-1346.
24. + human thymocytes. J. Exp. Med. (2002) 196:379-387.
25. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. (2002) 2:389-400.
26. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. (2001) 2:301-306.
27. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. (2004) 199:25-34.
28. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. (2003) 171:3435-3441.
29. + T cells. Int. Immunol. 2000 12:177-185.
30. YVON ES, VIGOUROUX S, ROUSSEAU RF et al.: Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood. (2003) 102:3815-3821.
31. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. (2002) 3:135-142.
32. BACH JF: Regulatory T cells under scrutiny. Nat. Rev. Immunol. (2003) 3:189-198.
33. + regulatory T cells. J. Immunol. (2003) 171:5678-5682.
34. BRUDER D, PROBST-KEPPER M, WESTENDORF AM et al.: Neuropilin- 1: a surface marker of regulatory T cells. Eur. J. Immunol. (2004) 34:623-630.
35. + T helper cells. Eur. J. Immunol. (2004) 34:1303-1311.
36. + regulatory T cells at the single-cell level. Eur. J. Immunol. (2005) 35:1681-1691.
37. BRUNKOW ME, JEFFERY EW, HJERRILD KA et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. (2001) 27:68-73.
38. HORI S, NOMURA T, SAKAGUCHI S: Control of regulatory T cell development of the transcription factor FoxP3. Science. (2003) 299:1057-1061.
39. + regulatory T cells by TGF-β induction of transcription factor FoxP3. J. Exp. Med. (2003) 198:1875-1886.
40. + T regulatory cells. Nat. Immunol. (2003) 4:337-342.
41. - T cells. J. Clin. Invest. (2003) 112:1437-1443.
42. FONTENOT JD, RASMUSSEN JP, WILLIAMS LM, DOOLEY JL, FARR AG, RUDENSKY AY: Regulatory T cell lineage specification by the forkhead transcription factor FoxP3. Immunity (2005) 22:329-341.
43. + T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA (2005) 102:4091-4096.
44. GRACA L: New tools to identify regulatory T cells. Eur. J. Immunol. (2005) 35:1678-1680.
45. + regulatory T cells at the single-cell level. Eur. J. Immunol. (2005) 35:1681-1691.
46. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. (2004) 172:4676-4680.
47. + regulatory T cells downregulate costimulatory molecules on antigen-presenting cells. Eur. J. Immunol. (2000) 30:1538-1543.
48. + T helper cells. J. Exp. Med. (2002) 196:255-260.
49. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent Type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247-253.
50. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. (2001) 194:629-644.
51. + regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. (2003) 14:85-89.
52. FALLARINO F, GROHMANN U, HWANG KW et al.: Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. (2003) 4:1206-1212.
53. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. (2005) 174:1783-1786.
54. GROSSMAN WJ, VERBSKY JW, BARCHET W, COLONNA M, ATKINSON JP, LEY TJ: Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. (2004) 21:589-601.
55. YOU S, BELGHITH M, COBBOLD S et al.: Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T cells. Diabetes. (2005) 54:1415-1422.
56. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. (2000) 164:240-247.
57. - thymocytes. J. Exp. Med. (1999) 189:279-288.
58. ASSEMAN C, MAUZE S, LEACH MW, COFFMAN RL, POWRIE F: An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. (1999) 190:995-1004.
59. + T cells. J. Exp. Med. (1996) 183:2669-2674.
60. + Treg cells. J. Autoimmun. (2001) 16:115-123.
61. AKBARI O, FREEMAN GJ, MEYER EH et al.: Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. (2002) 8:1024-1032.
62. + regulatory T cells. Int. Immunol. (2004) 16:249-256.
63. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. (2002) 168:1080-1086.
64. O'GARRA A, VIEIRA P: Regulatory T cells and mechanisms of immune system control. Nat. Med. (2004) 10:801-805.
65. + Tr cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. (2003) 197:111-119.
66. WAHL SM, SWISHER J, McCARTNEY-FRANCIS N, CHEN W: TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cell. J. Leuk. Biol. (2004) 76:15-24.
67. PAUST S, CANTOR H: Regulatory T cells and autoimmune disease. Immunol. Rev. (2005) 204:195-207.
68. + regulatory T cells. J. Exp. Med. (2005) 201:1061-1067.
69. - T cells through FoxP3 induction and down-regulation of Smad7. J. Immunol. (2004) 172:5149-5153.
70. + regulatory T cells from human peripheral blood. J. Immunol. (2001) 166:7282-7289.
71. + regulatory T cells. J. Exp. Med. (2005) 201:737-746.
72. NELSON BH: IL-2, regulatory T cells, and tolerance. J. Immunol. (2004) 172:3983-3988.
73. MALEK TR, BAYER AL: Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. (2004) 4:665-674.
74. + T cell suppressor function. J. Immunol. (2004) 172:6519-6523.
75. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. (2005) 201:723-735.
76. + cells controlling a pathogenic CD4 response inhibit cyrokine differentiation, CXCR-3 expression and tissue invasion. J. Immunol. (2004) 173:2942-2951.
77. + as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA (2002) 99:13031-13036.
78. + regulatory T cells. J. Exp. Med. (2001) 194:847-853.
79. H1 or T-regulatory 1 cytokine profile. J. Immunol. (2003) 171:159-165.
80. + regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. (2005) 174:7487-7491.
81. GROUX H: Type 1 T regulatory cells: Their role in the control of immune responses. Transplantation (2003) 75:8S-12S.
82. H1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195:603-616.
83. GRACA L, COBBOLD SP, WALDMANN: Identification of regulatory T cells in tolerated allografts. J. Exp. Med. (2002) 195:1641-1646.
84. RUTELLA S, RUMI C, SICA S, LEONE G: Recombinant human granulocyte colony-stimulating factor (rhG-CSF): effects on lymphocyte phenotype and function. J. Interf. Cytok. Res. (1999) 19:989-994.
85. VOLPI I, PERRUCCIO K, TOSTI A et al.: Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood. (2001) 97:2514-2521.
86. RUTELLA S, PIERELLI L, RUMI C et al.: T-cell apoptosis induced by granulocyte colony-stimulating factor (G-CSF) is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp. Hematol. (2001) 29:401-415.
87. RUTELLA S, RUMI C, LUCIA MB, SICA S, CAUDA R, LEONE G: Serum of healthy donors receiving recombinant human granulocyte colony-stimulating factor (rhG-CSF) induces T-cell unresponsiveness. Exp. Hematol. (1998) 26:1024-1033.
88. FRANZKE A, PIAO W, LAUBER J et al.: G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood (2003) 102:734-739.
89. RUTELLA S, PIERELLI L, BONANNO G et al.: Role for granulocyte colony-stimulating factor in the generation of human T regulatory Type 1 cells. Blood (2002) 100:2562-2571.
90. RUTELLA S, BONANNO G, PIERELLI L et al.: Granulocyte colony-stimulating factor promotes the generation of regulatory DCs through induction of IL-10 and IFN-α. Eur. J. Immunol. (2004) 34:1291-1302.
91. MORRIS ES, MACDONALD KPA, ROWE V et al.: Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood (2004) 103:3573-3581.
92. + T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. (2004) 172:1991-1995.
93. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. (2002) 169:4712-4716.
94. HAFLER DA, SLAVIK JM, ANDERSON DE, O'CONNOR KC, DE JAGER P, BEACHER-ALLAN C: Multiple sclerosis. Immunol. Rev. (2005) 204:208-231.
95. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. (2004) 199:971-979.
96. + regulatory T cells by copolimer-I through activation of transcription factor FoxP3. Proc. Natl. Acad. Sci. USA (2005) 102:6449-6454.
97. MIURA Y, THOBURN CJ, BRIGHT EC et al.: Association of FoxP3 regulatory gene expression with graft-versus-host disease. Blood. (2004) 104:2187-2193.
98. high regulatory T cells. Blood (2004) 103:2410-2416.
99. + regulatory T cells in patients with chronic graft-versus-host disease. Blood (2005) 106:2903-2911.
100. + regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arth. Rheum. (2005) 52:1180-1184.
101. + T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J. Immunol. (2005) 175:944-950.
102. + T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus (2004) 13:192-200.
103. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. (2004) 59:198-202.
104. HORWITZ DA, GRAY JD, ZHENG SG: The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. (2002) 4:241-246.
105. FIOCCHI C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 115:182-205.
106. ALLEZ M, MAYER L: Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. (2004) 10:666-676.
107. low subset. J. Exp. Med. (1990) 172:1701-1708.
108. STEINMAN RM, HAWIGER D, NUSSENZWEIG MC: Tolerogenic dendritic cells. Ann. Rev. Immunol. (2003) 21:685-711.
109. DE WINTER H, ELEWAUT D, TUROVSKAYA O et al.: Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology (2002) 122:1829-1841.
110. H1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195:603-616.
111. CONG Y, WEAVER CT, LAZENBY A, ELSON CO.: Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. (2002) 169:6112-6119.
112. WAIDMANN M, ALLEMAND Y, LEHMANN J et al.: Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-γ and TNF-α production. Gut. (2002) 50:170-179.
113. + T regulatory cells suppress helicobacter hepaticus-induced colitis. J. Exp. Med. (2002) 196:505-515.
114. NEURATH MF, FUSS I, KELSALL BL, PRESKY DH, WAEGELL W, STROBER W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. (1996) 183:2605-2616.
115. FUSS IJ, BOIRIVANT M, LACY B, STROBER W: The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. (2002) 168:900-908.
116. BOIRIVANT M, FUSS IJ, CHU A, STROBER W: Oxazolone colitis: a murine model of T helper cell Type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. (1998) 188:1929-1939.
117. bright T cells in human intestinal lamina propria as regulatory cells. J. Immunol. (2004) 173:3119-3130.
118. high T cells in inflammatory bowel disease. Gastroenterology. (2005) 128:1868-1878.
119. + regulatory T cells. J. Immunol. (2003) 170:3939-3943.
120. + regulatory T cells during autoimmune diabetes. J. Exp. Med. (2005) 201:1333-1346.
121. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity (2002) 16:183-191.
122. + T cells from patients with Type 1 diabetes. Diabetes (2005) 54:92-99.
123. + regulatory T cells. Diabetes (2005) 54:78-84.
124. VELDMAN C, HOHNE A, DIECKMANN D, SCHULER G, HERTL M: Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J. Immunol. (2004) 172:6468-6475.
125. + regulatory T cells control induction of autoimmune hemolytic anemia. Blood (2005) 105:3746-3748.
126. high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. (2005) 174:164-173.
127. + regulatory T cells in autoimmune polyglandular syndrome Type II. J. Exp. Med. (2004) 199:1285-1291.
128. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. (2003) 33:215H223.
129. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. (2004) 172:6435-6443.
130. + T cells and suppresses experimental autoimmune thyroiditis. J. Immunol. (2003) 170:5511-5522.
131. + regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. (2005) 174:7006-7013.
132. + T cells. J. Immunol. (2005) 174:7433-7439.
133. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood (2005) 105:735-741.
134. GAMBINERI E, TORGERSON TR, OCHS HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. (2003) 15:430-435.
135. BENNETT CL, CHRISTIE J, RAMSDELL F et al.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genetics (2001) 27:20-21.
136. BAUD O, GOULET O, CANIONI D et al.: Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. New Engl. J. Med. (2001) 344:1758-1762.
137. MAZZOLARI E, FORINO C, FONTANA M et al.: A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant. (2005) 35:1033-1034.
138. OCHS HD, ZIEGLER SF, TORGERSON TR: FOXP3 acts as a rheostat of the immune response. Immunol. Rev. (2005) 203:156-164.
139. SMYK-PEARSON SK, BAKKE AC, HELD PK, WILDIN RS: Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-entiched splenocytes. Clin. Exp. Immunol. (2003) 133:193-199.
140. BACCHETTA R, SARTIRANA C, LEVINGS MK, BORDIGNON C, NARULA S, RONCAROLO MG: Growth and expansion of human T regulatory Type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol. (2002) 32:2237-2245.
141. + T cells in the control of inflammation. J. Immunol. (2003) 171:5018-5026.
142. high regulatory T cells. Blood (2004) 104:895-903.
143. TANG Q, HENRIKSEN KJ, BI M et al.: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1455-1465.
144. + antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. USA (2004) 101:14622-14626.
145. + immunoregulatory T cells: New therapeutics for graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. (2002) 196:401-406.
146. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood. (2002) 99:3493-3499.
147. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. (2002) 196:389-399.
148. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. (2003) 9:1144-1150.
149. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. (2003) 112:1688-1696.
150. SATO K, YAMASHITA N, YAMASHITA N, MASANORI B, MATSUYAMA T: Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity (2003) 18:367-379.
151. SATO K, YAMASHITA N, BABA M, MATSUYAMA T: Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood (2003) 101:3581-3589.
152. MILLS KH: Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. (2004) 4:1-15.
153. TERABE M, BERZOFSKY JA: Immunoregulatory T cells in tumor immunity. Curr. Opin. Immunol. (2004) 16:157-162.
154. CURIEL TJ, COUKOS G, LINHUA Z et al.: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. (2004) 10:942-949.
155. WOLF AM, WOLF D, STEURER M, GASTL G, GUNSILIUS E, GRUBECK-LOEBENSTEIN B: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. (2003) 9:606-612.
156. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. (1999) 163:5211-5218.
157. + helper T cell responses in cancer patients. Blood (2005) 106:1008-1011.
158. + T regulatory cell activities in lung cancer. Cancer Res. (2005) 65:5211-5220.
159. + regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol (2004) 126:81-84.
160. ISHIDA T, IIDA S, AKATSUKA Y et al.: The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin. Cancer Res. (2004) 10:7529-7539.
161. RUTELLA S, RUMI C, TESTA U et al.: Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant. (1997) 20:355-364.
162. MALOY KJ, POWRIE F: Regulatory T cells in the control of immune pathology. Nat. Immunol. (2001) 2:816-822.
163. WOOD KJ, SAKAGUCHI S: Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. (2003) 3:199-210.
164. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. (2001) 193:1295-1302.
165. + regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin. Biol. Ther. (2005) 5:451-462.
166. + T cells. Clin. Immunol. (2005) 115:10-18.
167. BAAN CC, VAN DER MAST BJ, KLEPPER M et al.: Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FoxP3 in human T cells. Transplantation (2005) 80:110-117.
168. + regulatory T cells. Blood (2005) 105:4743-4748.
169. ZHENG XX, SANCHEZ-FUEYO A, SHO M, DOMENIC C, SAYEGH MH, STROM TB: Favorably tipping the balance between cytophatic and regulatory T cells to create transplantation tolerance. Immunity (2003) 19:503-514.